Google Backs Plan to Use CRISPR to Cure Heart Disease

Google Ventures has pumped money into Verve Therapeutics, a startup that wants to use CRISPR to create a "one-and-done" therapy for heart disease.

Big Money A new biotech startup has a bold plan to use CRISPR to end heart disease — and one of the world’s biggest tech companies is ready to help bring it to fruition. Verve Therapeutics came out of stealth mode on Tuesday with the announcement that it’d raised $58.5 million in financing, the majority of which came from GV […]

The post Google Backs Plan to Use CRISPR to Cure Heart Disease appeared first on Futurism.